Evaluation of mRNA by Q-RTPCR and protein expression by AQUA of the M2 subunit of ribonucleotide reductase (RRM2) in human tumors

被引：0
|
作者：
Jill Kolesar
Wei Huang
Jens Eickhoff
Kristine Hahn
Dona Alberti
Steven Attia
William Schelman
Kyle Holen
Anne Traynor
Percy Ivy
George Wilding
机构：
[1] University of Wisconsin Paul P. Carbone Comprehensive Cancer Center,School of Pharmacy
[2] University of Wisconsin,Department of Pathology
[3] University of Wisconsin School of Medicine and Public Health,Department of Biostatistics
[4] University of Wisconsin School of Medicine and Public Health,Department of Medicine
[5] University of Wisconsin School of Medicine and Public Health,Cancer Therapy and Evaluation Program
[6] National Cancer Institute,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2009年 / 64卷
关键词：
Triapine; 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone; Ribonucleotide reductase; Automated quantitative immunohistochemistry (AQUA); Quantitative real time PCR;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：79 / 86
页数：7
相关论文
共 50 条
  • [41] Overexpression of transfected human ribonucleotide reductase M2 subunit in human cancer cells enhances their invasive potential
    Zhou B.-S.
    Tsai P.
    Ker R.
    Tsai J.
    Ho R.
    Yu J.
    Shih J.
    Yen Y.
    Clinical & Experimental Metastasis, 1998, 16 (1) : 43 - 49
  • [42] Overexpression of transfected human ribonucleotide reductase M2 subunit in human cancer cells enhances their invasive potential
    Zhou, BS
    Tsai, P
    Ker, R
    Tsai, J
    Ho, R
    Yu, J
    Shih, J
    Yen, Y
    CLINICAL & EXPERIMENTAL METASTASIS, 1998, 16 (01) : 43 - 49
  • [43] Ribonucleotide reductase subunit M2 regulates Bcl-2 in human cancer: A potential target for cancer therapy
    Rahman, Mohammad Aminur
    Amin, A. R. M. R.
    Koenig, Lydia
    Nannapaneni, Sreenivas
    Chen, Zhuo G.
    Shin, Dong M.
    CANCER RESEARCH, 2012, 72
  • [44] SUBUNIT M2 OF MAMMALIAN RIBONUCLEOTIDE REDUCTASE - CHARACTERIZATION OF A HOMOGENEOUS PROTEIN ISOLATED FROM M2-OVERPRODUCING MOUSE CELLS
    THELANDER, M
    GRASLUND, A
    THELANDER, L
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1985, 260 (05) : 2737 - 2741
  • [45] Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer
    Mazzu, Ying Z.
    Armenia, Joshua
    Nandakumar, Subhiksha
    Chakraborty, Goutam
    Yoshikawa, Yuki
    Jehane, Lina E.
    Lee, Gwo-Shu Mary
    Atiq, Mohammad
    Khan, Nabeela
    Schultz, Nikolaus
    Kantoff, Philip W.
    MOLECULAR ONCOLOGY, 2020, 14 (08) : 1881 - 1897
  • [46] A comprehensive analysis of ribonucleotide reductase subunit M2 for carcinogenesis in pan-cancer
    Wang, Yong
    Chen, Rong
    Zhang, Jing
    Zeng, Peng
    PLOS ONE, 2024, 19 (04):
  • [47] The expression of ribonucleotide reductase subunit M2 is associated with nuclear localization of \#946;catenin and impact outcome of colorectal cancers
    Liu, Xiyong
    Lai, Lily
    Leora, Sofia
    He, Huiying
    Zhang, Kegiang
    Wang, Xiaochen
    Nelson, Rebecca
    Zhou, Bingsen
    Chu, Peiguo
    Yen, Yun
    CANCER RESEARCH, 2009, 69
  • [48] Ribonucleotide Reductase M2 Subunit Is a Novel Marker and a Potential Therapeutic Target for Gastric Carcinoma
    Morikawa, T.
    Hino, R.
    Uozaki, H.
    Ushiku, T.
    Sakatani, T.
    Inoue, Y.
    Shinozaki, A.
    Nakaya, T.
    Ishikawa, S.
    Fukayama, M.
    MODERN PATHOLOGY, 2009, 22 : 140A - 140A
  • [49] Ribonucleotide Reductase M2 Subunit Is a Novel Marker and a Potential Therapeutic Target for Gastric Carcinoma
    Morikawa, T.
    Hino, R.
    Uozaki, H.
    Ushiku, T.
    Sakatani, T.
    Inoue, Y.
    Shinozaki, A.
    Nakaya, T.
    Ishikawa, S.
    Fukayama, M.
    LABORATORY INVESTIGATION, 2009, 89 : 140A - 140A
  • [50] Inhibition of ribonucleotide reductase subunit M2 enhances the radiosensitivity of metastatic pancreatic neuroendocrine tumor
    Chow, Zeta
    Johnson, Jeremy
    Chauhan, Aman
    Jeong, Jong Cheol
    Castle, Jennifer T.
    Izumi, Tadahide
    Weiss, Heidi
    Townsend Jr, Courtney M.
    Schrader, Joerg
    Anthony, Lowell
    Yang, Eddy S.
    Evers, B. Mark
    Rychahou, Piotr
    CANCER LETTERS, 2024, 596
12345